Cargando…
DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
The BRCA1 gene product helps to maintain genomic integrity through its participation in the cellular response to DNA damage: specifically, the repair of double-stranded DNA breaks. An impaired cellular response to DNA damage is a plausible mechanism whereby BRCA1 mutation carriers are at increased r...
Autores principales: | Kotsopoulos, J, Chen, Z, Vallis, K A, Poll, A, Ainsworth, P, Narod, S A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360222/ https://www.ncbi.nlm.nih.gov/pubmed/17213827 http://dx.doi.org/10.1038/sj.bjc.6603528 |
Ejemplares similares
-
Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers
por: Clarke, C L, et al.
Publicado: (2006) -
Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Zaman, Tasnim, et al.
Publicado: (2019) -
Evaluation of models to predict BRCA germline mutations
por: Kang, H H, et al.
Publicado: (2006) -
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012) -
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2005)